Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Jasper Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get JSPR alerts

About William Lis

William Lis is recorded as CEO at Jasper Therapeutics, Inc. (JSPR). Jasper Therapeutics, Inc. reported in an 8-K filed November 1, 2023 that William Lis resigned as Chairperson of the Board, effective November 1, 2023. Jasper Therapeutics, Inc. reported in an 8-K filed November 1, 2023 that William Lis resigned as Board, effective December 14, 2023. The proxy statement of Jasper Therapeutics, Inc. reports total compensation of $679,289 for William Lis in fiscal 2021, including a base salary of $459,289. Disclosed compensation is on record for 2 fiscal years. Jasper Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Jasper Therapeutics, Inc. includes Jeet Mahal (CEO, COO and Board Member), Ronald Martell (CEO and Board Member), Howard Hoffen (Chairman) and 7 others.

“Additionally, effective upon Mr. Wiggans' appointment to the Board and as Chairperson of the Board, Mr. Lis stepped down as Chairperson of the Board.”
Jasper Therapeutics, Inc. Form 8-K, filed November 1, 2023 · Read the filing
“On October 30, 2023, William Lis notified the Board of his intent to resign from the Board effective as of December 14, 2023.”
Jasper Therapeutics, Inc. Form 8-K, filed November 1, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Jasper Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2021 Jasper Therapeutics, Inc. (JSPR) $459,289 $679,289
2020 Jasper Therapeutics, Inc. (JSPR) $399,627 $1,571,061

Recent activity